TRANSITION THERAPEUTICS
Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 for the treatment of Alzheimer's disease and TT223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using its proprietary drug discovery engine.
TRANSITION THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
1987-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.transitiontherapeutics.com
Total Employee:
11+
Status:
Closed
Contact:
416-260-7770
Email Addresses:
[email protected]
Total Funding:
41.8 M USD
Technology used in webpage:
SPF Network Solutions DNS AppRiver
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Ocera Therapeutics
Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Employees Featured
Founder
Stock Details
Investors List
Oracle Investment Management Inc.
Oracle Investment Management Inc. investment in Post-IPO Equity - Transition Therapeutics
Jack W. Schuler Living Trust
Jack W. Schuler Living Trust investment in Post-IPO Equity - Transition Therapeutics
Larry N. Feinberg
Larry N. Feinberg investment in Post-IPO Equity - Transition Therapeutics
Larry N. Feinberg
Larry N. Feinberg investment in Post-IPO Equity - Transition Therapeutics
Official Site Inspections
http://www.transitiontherapeutics.com
Unable to get host informations!!!
More informations about "Transition Therapeutics"
Home - Turn Therapeutics
Our Portfolio Explore Our Pipeline From Survivor to Founder What started as a desperate attempt at survival, Founder and CEO Bradley Burnam laid the groundwork with PermaFusion to build …See details»
OPKO Health Completes Acquisition of Transition …
Aug 31, 2016 MIAMI-- (BUSINESS WIRE)-- OPKO Health, Inc. (NASDAQ: OPK), announces that it has completed its previously announced acquisition of Transition Therapeutics, Inc. (NASDAQ: TTHI, TSX: TTH), by way of a plan of …See details»
Transition Bio – Cutting Edge Condensate Science
Solving the Unsolvable Redefining drug discovery at the molecular level By combining the technology and data engine of Harvard’s Weitz Lab and the University of Cambridge’s …See details»
Transition Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Jul 14, 2025 Explore Transition Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, and 5 literature, Disease Domain:Nervous System Diseases ...See details»
Transition Therapeutics 2025 Company Profile: …
Information on acquisition, funding, cap tables, investors, and executives for Transition Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Transition Therapeutics - Profiles & Contacts - Crunchbase
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.See details»
Transition Therapeutics Inc Company Profile - Dun & Bradstreet
Company Description: Transition Therapeutics would like to help people suffering from disease to make the transition to good health. The biotechnology firm is working on therapies to treat …See details»
Transition Therapeutics Inc. - Toronto, Canada - bionity.com
Oct 22, 2008 Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005/ AZD-103 …See details»
Transition Therapeutics Inc Overview - SignalHire
Transition Therapeutics Inc is a private company that has been in the industry for 25 years. Its headquarters is located at Toronto, Ontario, CA. The number of employees ranges from 1 to …See details»
Transition Therapeutics - 2025 Company Profile & Team - Tracxn
Jun 30, 2025 Transition Therapeutics - Small molecule therapeutics for CNS and metabolic diseases.. Acquired by Opko Health. Raised funding over 10 rounds from 2 investors.See details»
Transition Therapeutics Inc. - 101 College St #220, Toronto, ON
Transition Therapeutics Inc. Toronto postal code M5G 1L7. See Google profile, Phone, Fax, Email, Website and more for this business. 3.0 Cybo Score. Transition Therapeutics Inc. is …See details»
Transition Therapeutics - Radcliffe Cardiology
Transition Therapeutics Location 101 College Street Suite 220 Toronto Google MapsSee details»
Transition Therapeutics, Inc. (Transition Therapeutics, Inc.) - 药物管 …
了解Transition Therapeutics, Inc. (Transition Therapeutics, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6篇新闻和4篇文献，疾病领域:神经系统疾病，内分泌与代谢疾病，技术平台: …See details»
Transition Therapeutics - Financial Details - Crunchbase
Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.See details»
Transition Therapeutics Inc. and Waratah Pharmaceuticals Inc
Jan 15, 2002 WHEREASthe local securities regulatory authority or regulator (the "DecisionMaker") in each of Alberta, British Columbia, Saskatchewan, Ontarioand Québec …See details»
Tony Cruz - Founder & Chief Executive Officer - Crunchbase
Tony Cruz is the Founder & Chief Executive Officer at Transition Therapeutics. Additionally, Tony Cruz has had 3 past jobs including President & CEO at Canadian Arthritis Network.See details»
Transition Therapeutics - Products, Competitors, Financials, …
About Transition Therapeutics Transition Therapeutics is a biopharmaceutical development company aiming to advance novel therapeutics for CNS, metabolic diseases and androgen …See details»
Tony Cruz - Owner - Transition Therapeutics Inc | LinkedIn
Owner, Transition Therapeutics Inc · Experience: Transition Therapeutics Inc · Location: Toronto · 14 connections on LinkedIn. View Tony Cruz’s profile on LinkedIn, a professional community …See details»
Transition Therapeutics - Ownership and Business Overview - Mergr
Transition Therapeutics Inc. is a bio pharmaceutical company, develops therapeutics for various disease indications. Transition Therapeutics, Inc. was formed in 1987 and is based in Toronto, …See details»
Transition Therapeutics - Company Profile & Staff Directory
Transition Therapeutics is a Biopharma company located in Toronto, Ontario with 13 employees. Access Transition Therapeutics's email format and Transition Therapeutics staff directory for …See details»